The Medical Director, Oncology Clinical Development will report to the Executive Medical Director / Clinical Development Lead (CDL), Oncology Clinical Development. This position will support our growing oncology portfolio for the treatment of hematological malignancies, working across early‑to‑late stage development with a multidisciplinary team of oncology drug developers.
An on‑site office presence for a minimum of two days a week is required in one of GSK’s UK (London or Stevenage), US (Greater Philadelphia or Waltham), Switzerland (Zug) or Poland (Warsaw) campuses.